Allograft Dysfunction
📧 Sign up to get email alerts when something new happens for Allograft Dysfunction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation [Phase 2]
Phase 2 pilot trial evaluating Reparixin to prevent early allograft dysfunction after liver transplantation; the study was terminated but re…
-
CLINICAL_TRIALS research · 2020-07-31Clinical Trial Update: Controlled Attenuation Parameter (CAP) in Liver Allografts
A completed clinical trial examining the use of controlled attenuation parameter (CAP) to assess liver allografts in liver transplant patien…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus [NA]
A completed clinical trial evaluated tacrolimus flushing for use during liver transplantation to mitigate ischemia-reperfusion injury and ea…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients [Phase 4]
Phase 4 clinical trial update evaluating everolimus as rescue immunosuppression for chronic allograft dysfunction in renal transplant recipi…
-
CLINICAL_TRIALS research · 2013-02-22Clinical Trial Update: The Histological Analysis in Renal Transplantation Patients With Deterioration of Graft Function
An update on a clinical trial evaluating histological analysis in renal transplant patients with deterioration of graft function.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2011-05-23Clinical Trial Update: Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA) [Phase 2]
Phase 2 study of STX-100 in renal transplant recipients with interstitial fibrosis and tubular atrophy has been withdrawn.